Results 281 to 290 of about 4,926,176 (337)
Some of the next articles are maybe not open access.
Nature Reviews Drug Discovery, 2017
FDA approval count fell last year, despite a steady regulatory filing rate. FDA approval count fell last year, despite a steady regulatory filing rate.
openaire +2 more sources
FDA approval count fell last year, despite a steady regulatory filing rate. FDA approval count fell last year, despite a steady regulatory filing rate.
openaire +2 more sources
Nature Reviews Drug Discovery, 2018
This corrects the article DOI: 10.1038/nrd.2018.4.
openaire +3 more sources
This corrects the article DOI: 10.1038/nrd.2018.4.
openaire +3 more sources
First de novo deuterated drug poised for approval
Nature reviews. Drug discovery, 2022Asher Mullard
semanticscholar +1 more source
Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies
Ca-A Cancer Journal for Clinicians, 2022Paolo Tarantino +2 more
exaly
Cancer epigenetics in clinical practice
Ca-A Cancer Journal for Clinicians, 2023Veronica Davalos, Manel Esteller
exaly
Treatment of muscle‐invasive and advanced bladder cancer in 2020
Ca-A Cancer Journal for Clinicians, 2020Vaibhav G Patel +2 more
exaly
Alnylam prepares to land first RNAi drug approval
Nature reviews. Drug discovery, 2018Chris Morrison
semanticscholar +1 more source
An update on the immune landscape in lung and head and neck cancers
Ca-A Cancer Journal for Clinicians, 2020Jennifer W Carlisle +2 more
exaly